PT Siloam International Hospitals Tbk (IDX:SILO)

IDX:SILO Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	12,509,923	12,207,563	11,190,511	9,518,012	9,381,891	7,110,124
Revenue Growth (YoY)	3.66%	9.09%	17.57%	1.45%	31.95%	1.31%
Cost of Revenue	7,900,040	7,559,090	6,942,765	6,175,478	5,965,221	4,940,499
Gross Profit	4,609,883	4,648,473	4,247,746	3,342,534	3,416,670	2,169,625
Selling, General & Admin	2,810,643	2,692,387	2,369,046	2,154,189	2,218,108	1,677,442
Other Operating Expenses	207,661	330,527	116,368	149,336	103,091	91,205
Operating Expenses	3,018,304	3,022,914	2,485,414	2,303,525	2,321,199	1,768,647
Operating Income	1,591,579	1,625,559	1,762,332	1,039,009	1,095,471	400,978
Interest Expense	-107,082	-57,477	-51,860	-38,332	-37,916	-71,085
Interest & Investment Income	23,665	29,775	21,975	29,917	19,147	11,251
Earnings From Equity Investments	-	-	-91	-78	-	-24
Currency Exchange Gain (Loss)	-30,625	-27,359	-27,147	-16,677	-20,968	-10,386
Other Non Operating Income (Expenses)	-34,999	-38,579	-31,900	-29,532	-27,069	-20,084
EBT Excluding Unusual Items	1,442,538	1,531,919	1,673,309	984,307	1,028,665	310,650
Gain (Loss) on Sale of Investments	-	-11,131	-	-	-	-
Asset Writedown	-	-160,426	-6,900	-	-55,800	-
Pretax Income	1,442,538	1,360,362	1,666,409	984,307	972,865	310,650
Income Tax Expense	364,619	410,248	419,365	273,926	272,681	185,400
Earnings From Continuing Operations	1,077,919	950,114	1,247,044	710,381	700,184	125,250
Minority Interest in Earnings	-49,305	-47,962	-35,761	-13,886	-26,067	-9,087
Net Income	1,028,614	902,152	1,211,283	696,495	674,117	116,163
Net Income to Common	1,028,614	902,152	1,211,283	696,495	674,117	116,163
Net Income Growth	4.19%	-25.52%	73.91%	3.32%	480.32%	-
Shares Outstanding (Basic)	12,985	12,982	12,987	9,846	12,934	12,993
Shares Outstanding (Diluted)	13,043	13,039	13,035	9,867	12,937	12,993
Shares Change (YoY)	0.24%	0.03%	32.11%	-23.73%	-0.43%	-0.10%
EPS (Basic)	79.22	69.49	93.27	70.74	52.12	8.94
EPS (Diluted)	78.87	69.19	92.92	70.59	52.11	8.94
EPS Growth	3.94%	-25.54%	31.63%	35.46%	482.88%	-
Free Cash Flow	563,458	692,816	670,608	505,036	1,408,498	972,653
Free Cash Flow Per Share	43.20	53.13	51.45	51.18	108.87	74.86
Dividend Per Share	-	-	20.000	19.670	-	17.375
Dividend Growth	-	-	1.68%	-	-	-
Gross Margin	36.85%	38.08%	37.96%	35.12%	36.42%	30.51%
Operating Margin	12.72%	13.32%	15.75%	10.92%	11.68%	5.64%
Profit Margin	8.22%	7.39%	10.82%	7.32%	7.18%	1.63%
Free Cash Flow Margin	4.50%	5.67%	5.99%	5.31%	15.01%	13.68%
EBITDA	2,074,509	2,081,545	2,239,849	1,545,181	1,602,513	895,219
EBITDA Margin	16.58%	17.05%	20.02%	16.23%	17.08%	12.59%
D&A For EBITDA	482,930	455,986	477,517	506,172	507,042	494,241
EBIT	1,591,579	1,625,559	1,762,332	1,039,009	1,095,471	400,978
EBIT Margin	12.72%	13.32%	15.75%	10.92%	11.68%	5.64%
Effective Tax Rate	25.28%	30.16%	25.17%	27.83%	28.03%	59.68%
Revenue as Reported	12,509,923	12,207,563	11,190,511	9,518,012	9,381,891	7,110,124

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.